A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-08) →
What happened
HLB Pharmaceutical updated the terms of a new share issuance to raise US$78M, about 28.1% of its market value.
For context, this raise equals about 28.1% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$78M |
| vs. market value | 28.1% |
| Filed | 2026-06-18, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260618000270 → open original filing |
Versions of this filing
- 2026-05-13Original
- 2026-06-18Amendment 1 (this page)
- 2026-08-03Amendment 2
- 2026-09-08Amendment 3
Source: DART. Information only, not investment advice.